Startup | August 20, 2021
Navia Life Care raises US $ 1 million in Series A funding
The company plans to invest in technology, business development, product innovation, and development across India
The company plans to invest in technology, business development, product innovation, and development across India
The project is a collaboration between IIT Delhi and AIIMS
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The agreements between the parties involve a total fee of Rs. 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Subscribe To Our Newsletter & Stay Updated
